The Finnish arm of EATRIS consists of nine institutes across Finland. The institutes contribute to four of the five EATRIS platforms; Biomarkers, Imaging and Tracers, Small Molecules and Advanced Therapy Medicinal Products (ATMP)

Together, they provide a wide range of services to the EATRIS infrastructure in the areas of molecular diagnostic assays, assay development, and production of molecular research and clinical tools, such as imaging, viral vectors, antibodies and tracer production.

In addition to their excellence in translational medicine, the EATRIS centers in Finland have key insight into process standardization, regulatory aspects, technology transfer, as well as clinical utilization.